![Figure 1 | Non-inferiority of dose reduction versus standard dosing of TNF-inhibitors in axial spondyloarthritis | SpringerLink Figure 1 | Non-inferiority of dose reduction versus standard dosing of TNF-inhibitors in axial spondyloarthritis | SpringerLink](https://media.springernature.com/full/springer-static/image/art%3A10.1186%2Fs13075-018-1772-z/MediaObjects/13075_2018_1772_Fig1_HTML.png)
Figure 1 | Non-inferiority of dose reduction versus standard dosing of TNF-inhibitors in axial spondyloarthritis | SpringerLink
![Parent Artery Reconstruction for Large or Giant Cerebral Aneurysms Using the Tubridge Flow Diverter: A Multicenter, Randomized, Controlled Clinical Trial (PARAT) | American Journal of Neuroradiology Parent Artery Reconstruction for Large or Giant Cerebral Aneurysms Using the Tubridge Flow Diverter: A Multicenter, Randomized, Controlled Clinical Trial (PARAT) | American Journal of Neuroradiology](http://www.ajnr.org/content/ajnr/early/2018/03/29/ajnr.A5619/F1.large.jpg)
Parent Artery Reconstruction for Large or Giant Cerebral Aneurysms Using the Tubridge Flow Diverter: A Multicenter, Randomized, Controlled Clinical Trial (PARAT) | American Journal of Neuroradiology
![Subject disposition. FAS: full analysis set, PP: per protocol, ITT:... | Download Scientific Diagram Subject disposition. FAS: full analysis set, PP: per protocol, ITT:... | Download Scientific Diagram](https://www.researchgate.net/publication/43131752/figure/fig1/AS:203148061876225@1425445680040/Subject-disposition-FAS-full-analysis-set-PP-per-protocol-ITT-intention-to-treat.png)
Subject disposition. FAS: full analysis set, PP: per protocol, ITT:... | Download Scientific Diagram
![Biolimus-Coated Balloon in Small-Vessel Coronary Artery Disease: The BIO-RISE CHINA Study - ScienceDirect Biolimus-Coated Balloon in Small-Vessel Coronary Artery Disease: The BIO-RISE CHINA Study - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1936879822006902-fx1.jpg)
Biolimus-Coated Balloon in Small-Vessel Coronary Artery Disease: The BIO-RISE CHINA Study - ScienceDirect
![Immunogenicity and safety of an adjuvanted inactivated polio vaccine, IPV-Al, compared to standard IPV: A phase 3 observer-blinded, randomised, controlled trial in infants vaccinated at 6, 10, 14 weeks and 9 months Immunogenicity and safety of an adjuvanted inactivated polio vaccine, IPV-Al, compared to standard IPV: A phase 3 observer-blinded, randomised, controlled trial in infants vaccinated at 6, 10, 14 weeks and 9 months](https://ars.els-cdn.com/content/image/1-s2.0-S0264410X19314446-gr1.jpg)
Immunogenicity and safety of an adjuvanted inactivated polio vaccine, IPV-Al, compared to standard IPV: A phase 3 observer-blinded, randomised, controlled trial in infants vaccinated at 6, 10, 14 weeks and 9 months
![Patient disposition. FAS, full analysis set; PPS, per-protocol set;... | Download Scientific Diagram Patient disposition. FAS, full analysis set; PPS, per-protocol set;... | Download Scientific Diagram](https://www.researchgate.net/publication/282658430/figure/fig1/AS:614292030255134@1523470041367/Patient-disposition-FAS-full-analysis-set-PPS-per-protocol-set-SAS-safety-analysis.png)
Patient disposition. FAS, full analysis set; PPS, per-protocol set;... | Download Scientific Diagram
![PPT - Robert O'Neill , Ph.D. Director, Office of Biostatistics, CDER, FDA PowerPoint Presentation - ID:9487710 PPT - Robert O'Neill , Ph.D. Director, Office of Biostatistics, CDER, FDA PowerPoint Presentation - ID:9487710](https://image5.slideserve.com/9487710/roles-of-the-different-analysis-sets-l.jpg)
PPT - Robert O'Neill , Ph.D. Director, Office of Biostatistics, CDER, FDA PowerPoint Presentation - ID:9487710
![The All Randomized/Full Analysis Set (ICH E9)—May Patients Be Excluded from the Analysis?* | Semantic Scholar The All Randomized/Full Analysis Set (ICH E9)—May Patients Be Excluded from the Analysis?* | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/a000d1a89a3db891de4b3bb3228abdc3279a2e86/2-Table1-1.png)
The All Randomized/Full Analysis Set (ICH E9)—May Patients Be Excluded from the Analysis?* | Semantic Scholar
![Bio-optimized Curcuma longa extract is efficient on knee osteoarthritis pain: a double-blind multicenter randomized placebo controlled three-arm study | Arthritis Research & Therapy | Full Text Bio-optimized Curcuma longa extract is efficient on knee osteoarthritis pain: a double-blind multicenter randomized placebo controlled three-arm study | Arthritis Research & Therapy | Full Text](https://media.springernature.com/full/springer-static/image/art%3A10.1186%2Fs13075-019-1960-5/MediaObjects/13075_2019_1960_Fig1_HTML.png)
Bio-optimized Curcuma longa extract is efficient on knee osteoarthritis pain: a double-blind multicenter randomized placebo controlled three-arm study | Arthritis Research & Therapy | Full Text
![Subject disposition. FAS: full analysis set, PP: per protocol, ITT:... | Download Scientific Diagram Subject disposition. FAS: full analysis set, PP: per protocol, ITT:... | Download Scientific Diagram](https://www.researchgate.net/publication/43131752/figure/fig1/AS:203148061876225@1425445680040/Subject-disposition-FAS-full-analysis-set-PP-per-protocol-ITT-intention-to-treat_Q320.jpg)
Subject disposition. FAS: full analysis set, PP: per protocol, ITT:... | Download Scientific Diagram
![Dydrogesterone treatment for menstrual-cycle regularization in abnormal uterine bleeding – ovulation dysfunction patients Dydrogesterone treatment for menstrual-cycle regularization in abnormal uterine bleeding – ovulation dysfunction patients](https://f6publishing.blob.core.windows.net/7a511a73-ec80-4c4e-8715-5ad56781581c/WJCC-8-3259-g001.png)
Dydrogesterone treatment for menstrual-cycle regularization in abnormal uterine bleeding – ovulation dysfunction patients
![Anti-SARS-CoV-2 antibody-containing plasma improves outcome in patients with hematologic or solid cancer and severe COVID-19: a randomized clinical trial | Nature Cancer Anti-SARS-CoV-2 antibody-containing plasma improves outcome in patients with hematologic or solid cancer and severe COVID-19: a randomized clinical trial | Nature Cancer](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs43018-022-00503-w/MediaObjects/43018_2022_503_Fig1_HTML.png)
Anti-SARS-CoV-2 antibody-containing plasma improves outcome in patients with hematologic or solid cancer and severe COVID-19: a randomized clinical trial | Nature Cancer
![INSTEAD: a randomised switch trial of indacaterol versus salmeterol/fluticasone in moderate COPD | European Respiratory Society INSTEAD: a randomised switch trial of indacaterol versus salmeterol/fluticasone in moderate COPD | European Respiratory Society](https://erj.ersjournals.com/content/erj/44/6/1548/F2.large.jpg)
INSTEAD: a randomised switch trial of indacaterol versus salmeterol/fluticasone in moderate COPD | European Respiratory Society
![Subject disposition. AE adverse event, FAS full analysis set, PPAS per... | Download Scientific Diagram Subject disposition. AE adverse event, FAS full analysis set, PPAS per... | Download Scientific Diagram](https://www.researchgate.net/publication/305749526/figure/fig2/AS:390949709598723@1470221082109/Subject-disposition-AE-adverse-event-FAS-full-analysis-set-PPAS-per-protocol-analysis.png)
Subject disposition. AE adverse event, FAS full analysis set, PPAS per... | Download Scientific Diagram
![Patient disposition. SAF, safety analysis set; FAS, full analysis set;... | Download Scientific Diagram Patient disposition. SAF, safety analysis set; FAS, full analysis set;... | Download Scientific Diagram](https://www.researchgate.net/publication/51712568/figure/fig3/AS:280374765735962@1443857961681/Patient-disposition-SAF-safety-analysis-set-FAS-full-analysis-set-PPS-per-protocol.png)
Patient disposition. SAF, safety analysis set; FAS, full analysis set;... | Download Scientific Diagram
![Nafamostat in hospitalized patients with moderate to severe COVID-19 pneumonia: a randomised Phase II clinical trial - eClinicalMedicine Nafamostat in hospitalized patients with moderate to severe COVID-19 pneumonia: a randomised Phase II clinical trial - eClinicalMedicine](https://www.thelancet.com/cms/attachment/8aea90d0-4665-4493-a4fe-b03d292cb58c/gr1_lrg.jpg)